These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 14727848)

  • 1. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes.
    Bonferoni MC; Rossi S; Ferrari F; Stavik E; Pena-Romero A; Caramella C
    AAPS PharmSciTech; 2000 Jun; 1(2):E15. PubMed ID: 14727848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of complex solubility on formulations based on lambda carrageenan and basic drugs.
    Aguzzi C; Bonferoni MC; Fortich MR; Rossi S; Ferrari F; Caramella C
    AAPS PharmSciTech; 2002; 3(3):E27. PubMed ID: 12916942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a diltiazem-lambda carrageenan complex.
    Bonferoni MC; Rossi S; Ferrari F; Bettinetti GP; Caramella C
    Int J Pharm; 2000 May; 200(2):207-16. PubMed ID: 10867250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies on polyelectrolyte complexes and mixtures of chitosan-alginate and chitosan-carrageenan as prolonged diltiazem clorhydrate release systems.
    Tapia C; Escobar Z; Costa E; Sapag-Hagar J; Valenzuela F; Basualto C; Gai MN; Yazdani-Pedram M
    Eur J Pharm Biopharm; 2004 Jan; 57(1):65-75. PubMed ID: 14729081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of oral controlled-release tablet formulations based on diltiazem-carrageenan complex.
    Bonferoni MC; Rossi S; Ferrari F; Caramella C
    Pharm Dev Technol; 2004; 9(2):155-62. PubMed ID: 15202574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pH, buffer capacity and ionic strength on quetiapine fumarate release from matrix tablets prepared using two different polymeric blends.
    Hamed R; AlJanabi R; Sunoqrot S; Abbas A
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1330-1342. PubMed ID: 28402145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
    Asare-Addo K; Conway BR; Larhrib H; Levina M; Rajabi-Siahboomi AR; Tetteh J; Boateng J; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Nov; 111():384-91. PubMed ID: 23850747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
    Mandal S; Ray R; Basu SK; Sa B
    J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug release from complexes with a series of poly(carboxyalkyl methacrylates), a new class of weak polyelectrolytes.
    Cornejo-Bravo JM; Flores-Guillen ME; Lugo-Medina E; Licea-Claverie A
    Int J Pharm; 2005 Nov; 305(1-2):52-60. PubMed ID: 16226001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug release kinetics and front movement in matrix tablets containing diltiazem or metoprolol/λ-carrageenan complexes.
    Bettini R; Bonferoni MC; Colombo P; Zanelotti L; Caramella C
    Biomed Res Int; 2014; 2014():671532. PubMed ID: 25045689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of dissolution medium on the release of diltiazem hydrochloride from carbomeric matrices].
    Sedláková M; Rabisková M; Svajdlenka E
    Ceska Slov Farm; 2006 Mar; 55(2):65-71. PubMed ID: 16570583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release of highly water-soluble drugs with micelle forming ability from polyionic matrix tablets.
    Tanaka Y; Miyazaki Y; Yakou S; Takayama K
    Pharmazie; 2007 Jan; 62(1):41-5. PubMed ID: 17294812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of polymer molecular weight and of polymer blends on the properties of rapidly gelling nasal inserts.
    Bertram U; Bodmeier R
    Drug Dev Ind Pharm; 2012 Jun; 38(6):659-69. PubMed ID: 22537309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.
    Thommes M; Kleinebudde P
    AAPS PharmSciTech; 2007 Nov; 8(4):E95. PubMed ID: 18181555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride.
    Toti US; Aminabhavi TM
    J Control Release; 2004 Mar; 95(3):567-77. PubMed ID: 15023467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parameters affecting the drug release from in situ gelling nasal inserts.
    Bertram U; Bodmeier R
    Eur J Pharm Biopharm; 2006 Jul; 63(3):310-9. PubMed ID: 16513333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L; Rabisková M; Medvecká G
    Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of nifedipine controlled release tablets prepared using mucoadhesive swellable polymer.
    Felician WA; Ghaly ES
    Pharm Dev Technol; 2011 Oct; 16(5):536-41. PubMed ID: 20954856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
    Liu F; Moreno P; Basit AW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.